# Evrionta Development Analysis

Investment materials for Thumbay Group strategic partnership.

## Overview

Comprehensive analysis comparing two approaches to building Evrionta platform:
1. **Build from Scratch**: $12.5M, 18-24 months
2. **H4U Platform Adaptation**: $6.6M, 10-12 months âœ…

## Documents

ðŸ“„ [Russian Version (Ð ÑƒÑÑÐºÐ°Ñ Ð²ÐµÑ€ÑÐ¸Ñ)](https://komoroshin.github.io/evrionta-development-comparison/evrionta-development-comparison-ru.html) - Comprehensive analysis with detailed budget breakdown, team structure, and monthly timeline.

ðŸ“„ [English Version](https://komoroshin.github.io/evrionta-development-comparison/evrionta-development-comparison.html) - Build from scratch vs H4U adaptation comparison.

## Key Highlights

### Platform Economics
- **FREE tier** for Ð²Ñ€Ð°Ñ‡ÐµÐ¹ with 4 revenue streams:
  - Pharma engagement (CPM/CPC/CPA)
  - Commerce marketplace (10-25% revenue share)
  - Payer outcomes contracts
  - RWE data products

### Market Validation (2025-2026)
- AI Medical Scribe: Abridge $5.3B, Suki $168M funding
- Healthcare AI: Median Series A >$50M, Series B $143M
- Clinical AI: Hippocratic AI $1.64B, OpenEvidence $3.5B
- Chronic Care: Virta $2B, Omada $1.2B IPO

### Valuation Projections
- **Seed** (months 0-12): $35-50M at 300 Ð²Ñ€Ð°Ñ‡ÐµÐ¹, $1.8M ARR
- **Series A** (months 18-24): $120-180M at 800-1,200 Ð²Ñ€Ð°Ñ‡ÐµÐ¹, $5-10M ARR
- **Series B** (months 30-36): $500M-800M at 2,500 Ð²Ñ€Ð°Ñ‡ÐµÐ¹, $30M ARR

### ROI for Seed Investor
- **15-25x return** by Series B (24-36 months)
- Exit scenarios: Acquisition at $1-2B or IPO at $2-4B

## Strategic Partnership

**Thumbay Group** (UAE):
- 100+ Ð²Ñ€Ð°Ñ‡ÐµÐ¹ captive pilot base
- 50+ pharmacies distribution network
- Medical university research partnership
- GCC market access

## Technology Stack

**Production-Ready from H4U:**
- âœ… AI Medical Scribe with voice control
- âœ… FHIR/EHR integration (SMART on FHIR)
- âœ… Mobile apps (iOS/Android published)
- âœ… Wearables sync (Apple Health, Google Fit)
- âœ… Telemedicine module (text chat + AI agent)
- âœ… Voice interface (full Ð²Ñ€Ð°Ñ‡ control)

## Budget: $6.6M (12 months)

- **Development**: $2.0M
- **Compliance & Legal**: $900K
- **Infrastructure**: $300K
- **Go-to-Market**: $1.8M
- **Operations**: $1.6M

## Timeline

- **Month 3**: Thumbay pilot validated (10 Ð²Ñ€Ð°Ñ‡ÐµÐ¹, UAE)
- **Month 6**: Thumbay rollout complete (100 Ð²Ñ€Ð°Ñ‡ÐµÐ¹)
- **Month 10**: First pharma contract, 200 Ð²Ñ€Ð°Ñ‡ÐµÐ¹ across GCC
- **Month 12**: Seed complete, Series A materials ready

---

**Prepared for**: Thumbay Group Strategic Investment
**Date**: February 2026
**Platform**: H4U Adaptation â†’ Evrionta
